Cipher Pharmaceuticals Inc. (TSE: CPH) Q2 2022 earnings call dated Aug. 12, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Scott Langille -- Chief
Cipher Pharmaceuticals Inc. (CPH) Q2 2022 Earnings Call Transcript
Categories
Health Care
Cardinal Health Inc. (CAH) Q4 2022 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q4 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike
Illumina, Inc. (ILMN) Q2 2022 Earnings Call Transcript
Illumina, Inc. (NASDAQ: ILMN) Q2 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Salli Schwartz -- Vice President of Investor Relations Francis deSouza -- Chief
Veru Inc. (VERU) Q3 2022 Earnings Call Transcript
Veru Inc. (NASDAQ: VERU) Q3 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Samuel Fisch -- Executive Director, Investor Relations & Corporate Communications
CATALYST PHARMACEUTICALS INC (CPRX) Q2 2022 Earnings Call Transcript
CATALYST PHARMACEUTICALS INC (NASDAQ: CPRX) Q2 2022 earnings call dated Aug. 10, 2022 Corporate Participants: Alicia Grande -- Chief Financial Officer Patrick J. McEnany -- Co-Founder, Chairman,
BioLife Solutions Inc. (BLFS) Q2 2022 Earnings Call Transcript
BioLife Solutions Inc. (NASDAQ: BLFS) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman &
Perrigo Co PLC (PRGO) Q2 2022 Earnings Call Transcript
Perrigo Co PLC (NYSE: PRGO) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Bradley Joseph -- Vice President, Global Investor Relations and
PetIQ, Inc. (PETQ) Q2 2022 Earnings Call Transcript
PetIQ, Inc. (NASDAQ: PETQ) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Katie Turner -- Investor Relations McCord Christensen -- Chief Executive Officer and
Trxade will focus more on core biz, connect with POS systems: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) has been on a mission to digitalize the retail pharmacy experience by providing a platform for independent
10X Genomics Inc. (TXG) Q2 2022 Earnings Call Transcript
10X Genomics Inc. (NASDAQ: TXG) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Cassie Corneau -- Investor Relations Serge Saxonov -- Chief Executive Officer,
Cara Therapeutics , Inc. (CARA) Q2 2022 Earnings Call Transcript
Cara Therapeutics , Inc. (NASDAQ: CARA) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Iris Francesconi -- Chief Strategy Officer and Head
ANI Pharmaceuticals, Inc. (ANIP) Q2 2022 Earnings Call Transcript
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Lisa M. Wilson -- Investor Relations Nikhil Lalwani -- President and
FibroGen, Inc. (FGEN) Q2 2022 Earnings Call Transcript
FibroGen, Inc. (NASDAQ: FGEN) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Michael Tung -- Vice President of Corporate Strategy and Investor
Canopy Growth Corporation (WEED) Q1 2023 Earnings Call Transcript
Canopy Growth Corporation (TSE : WEED) Q1 2023 earnings call dated Aug. 05, 2022 Corporate Participants: Tyler Burns -- Director of Investor Relations David
Amgen Inc. (AMGN) Q2 2022 Earnings Call Transcript
Amgen Inc. (NASDAQ: AMGN) Q2 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Arvind Sood -- Vice President, Investor Relations Robert A. Bradway -- Chairman
ABIOMED, Inc. (ABMD) Q1 2023 Earnings Call Transcript
ABIOMED, Inc. (NASDAQ: ABMD) Q1 2023 earnings call dated Aug. 04, 2022 Corporate Participants: Nicole Nath -- Manager of Investor Relations Michael R. Minogue -- Chairman,
Cigna Corporation (CI) Q2 2022 Earnings Call Transcript
Cigna Corporation (NYSE: CI) Q2 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Ralph Giacobbe -- Senior Vice President and Head of Investor
Zoetis Inc. (ZTS) Q2 2022 Earnings Call Transcript
Zoetis Inc. (NYSE: ZTS) Q2 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Steven Frank -- Vice President of Investor Relation Kristin C.
Eli Lilly and Company (LLY) Earnings: 2Q22 Key Numbers
Eli Lilly and Company (NYSE: LLY) reported second quarter 2022 earnings results today. Worldwide revenue decreased 4% to $6.49 billion compared to the
Moderna, Inc. (MRNA) Q1 2022 Earnings Call Transcript
Moderna, Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Lavina Talukdar -- Senior Vice President and Head of Investor
Regeneron Pharmaceuticals Inc. (REGN) Q2 2022 Earnings Call Transcript
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q2 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Ryan Crowe -- Vice President of Investor Relations Leonard